Iradimed Corp. (IRMD) Tops Q3 EPS by 7c

Iradimed Corp. (NASDAQ: IRMD) reported Q3 EPS of $0.43, $0.07 better than the analyst estimate of $0.36. Revenue for the quarter came in at $16.5 million versus the consensus estimate of $16.18 million.

For earnings history and earnings-related data on Iradimed Corp. (IRMD) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Pfizer lung cancer drug misses survival goal in Phase 3 trial
• Ridgepost Capital acquires Stellus Capital Management for $4B AUM